Publications by authors named "Victoria Dourdil"

Claim this Profile
R
Randomized phase II study of weekly carfilzomib 70 mg/m and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients.
Borja Puertas, Verónica González-Calle, Anna Sureda, María José Moreno, Albert Oriol, Victoria Dourdil

Haematologica· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.
Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, Laura Rosiñol, María-Jesús Blanchard, Victoria Dourdil

Blood Cancer J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group.
Enrique M Ocio, Cristina Motlló, Paula Rodríguez-Otero, Joaquín Martínez-López, Mª José Cejalvo, Mª Victoria Dourdil

Br J Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature.
Ramón Lecumberri, Isabel Krsnik, Elham Askari, Maialen Sirvent, Marta S González-Pérez, Victoria Dourdil

Amyloid· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation.
Gemma Azaceta, Maria J Calasanz, Victoria Dourdil, Elena Bonafonte, Isabel Izquierdo

Leuk Lymphoma· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis